Organisation paid for research Program year 2024 Source: CMS Open Payments

Advanced Cardiovascular LLC Admin Office

Neither a doctor nor a teaching hospital

Research payments

$61,783

10 payments

Through program year 2024, Advanced Cardiovascular LLC Admin Office is reported as receiving $61,783 in research payments, across 10 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$10,000	1
2023	Research	$2,365	1
2022	Research	$16,204	2
2021	Research	$23,454	5
2020	Research	$9,759	1

Breakdown

Who paid Research payments · program years 2020–2024

Boehringer Ingelheim Pharma GmbH & Co.KG $35,784 3 payments
Boehringer Ingelheim International GmbH $15,999 6 payments
Bayer HealthCare Pharmaceuticals Inc. $10,000 1 payment

Studies the money was for Research payments · program years 2020–2024

Empagliflozin for prevention of HHF and death after an AMI $33,213 6 payments
Empagliflozin for prevention of HHF and death afte $18,569 3 payments
BAY 1021189, A Phase 2b open-label clinical study to evaluate the tolerability and safety of an initiation dose of 5 mg of Vericiguat in participants with chronic heart failure with reduced ejection fraction $10,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.